Silverarc Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-99,379
| Closed | -$298K | – | 76 |
|
|
2024
Q2 | $298K | Hold |
99,379
| – | – | 0.07% | 63 |
|
|
2024
Q1 | $462K | Sell |
99,379
-621
| -0.6% | -$2.89K | 0.13% | 66 |
|
|
2023
Q4 | $414K | Hold |
100,000
| – | – | 0.12% | 62 |
|
|
2023
Q3 | $300K | Buy |
+100,000
| New | +$300K | 0.09% | 62 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 92 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 80 |
|
|
2021
Q3 | – | Sell |
-46,729
| Closed | -$1.5K | – | 98 |
|
|
2021
Q2 | $1.5K | Buy |
+46,729
| New | +$1.5K | 0.67% | 53 |
|